These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 23442912)
21. Regulation of the PTEN phosphatase. Gericke A; Munson M; Ross AH Gene; 2006 Jun; 374():1-9. PubMed ID: 16675164 [TBL] [Abstract][Full Text] [Related]
22. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors. Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919 [TBL] [Abstract][Full Text] [Related]
23. A new class of cancer-associated PTEN mutations defined by membrane translocation defects. Nguyen HN; Yang JM; Rahdar M; Keniry M; Swaney KF; Parsons R; Park BH; Sesaki H; Devreotes PN; Iijima M Oncogene; 2015 Jul; 34(28):3737-43. PubMed ID: 25263454 [TBL] [Abstract][Full Text] [Related]
24. Acute regulation of the tumour suppressor phosphatase, PTEN, by anionic lipids and reactive oxygen species. Downes CP; Walker S; McConnachie G; Lindsay Y; Batty IH; Leslie NR Biochem Soc Trans; 2004 Apr; 32(Pt 2):338-42. PubMed ID: 15046604 [TBL] [Abstract][Full Text] [Related]
25. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes. Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863 [TBL] [Abstract][Full Text] [Related]
26. The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif. Walker SM; Leslie NR; Perera NM; Batty IH; Downes CP Biochem J; 2004 Apr; 379(Pt 2):301-7. PubMed ID: 14711368 [TBL] [Abstract][Full Text] [Related]
27. Molecular mechanism of membrane binding of the GRP1 PH domain. Lai CL; Srivastava A; Pilling C; Chase AR; Falke JJ; Voth GA J Mol Biol; 2013 Sep; 425(17):3073-90. PubMed ID: 23747485 [TBL] [Abstract][Full Text] [Related]
28. PTEN Regulates PI(3,4)P Malek M; Kielkowska A; Chessa T; Anderson KE; Barneda D; Pir P; Nakanishi H; Eguchi S; Koizumi A; Sasaki J; Juvin V; Kiselev VY; Niewczas I; Gray A; Valayer A; Spensberger D; Imbert M; Felisbino S; Habuchi T; Beinke S; Cosulich S; Le Novère N; Sasaki T; Clark J; Hawkins PT; Stephens LR Mol Cell; 2017 Nov; 68(3):566-580.e10. PubMed ID: 29056325 [TBL] [Abstract][Full Text] [Related]
29. Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor. Georgescu MM; Kirsch KH; Kaloudis P; Yang H; Pavletich NP; Hanafusa H Cancer Res; 2000 Dec; 60(24):7033-8. PubMed ID: 11156408 [TBL] [Abstract][Full Text] [Related]
30. Regulation and modulation of PTEN activity. Naderali E; Khaki AA; Rad JS; Ali-Hemmati A; Rahmati M; Charoudeh HN Mol Biol Rep; 2018 Dec; 45(6):2869-2881. PubMed ID: 30145641 [TBL] [Abstract][Full Text] [Related]
31. The C-terminal tail inhibitory phosphorylation sites of PTEN regulate its intrinsic catalytic activity and the kinetics of its binding to phosphatidylinositol-4,5-bisphosphate. Chia YC; Catimel B; Lio DS; Ang CS; Peng B; Wu H; Zhu HJ; Cheng HC Arch Biochem Biophys; 2015 Dec; 587():48-60. PubMed ID: 26471078 [TBL] [Abstract][Full Text] [Related]
32. Interactions of peripheral proteins with model membranes as viewed by molecular dynamics simulations. Kalli AC; Sansom MS Biochem Soc Trans; 2014 Oct; 42(5):1418-24. PubMed ID: 25233425 [TBL] [Abstract][Full Text] [Related]
34. Kinetics of PTEN-mediated PI(3,4,5)P3 hydrolysis on solid supported membranes. Liu C; Deb S; Ferreira VS; Xu E; Baumgart T PLoS One; 2018; 13(2):e0192667. PubMed ID: 29447222 [TBL] [Abstract][Full Text] [Related]
35. A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN. Rahdar M; Inoue T; Meyer T; Zhang J; Vazquez F; Devreotes PN Proc Natl Acad Sci U S A; 2009 Jan; 106(2):480-5. PubMed ID: 19114656 [TBL] [Abstract][Full Text] [Related]
36. SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane. Huang J; Yan J; Zhang J; Zhu S; Wang Y; Shi T; Zhu C; Chen C; Liu X; Cheng J; Mustelin T; Feng GS; Chen G; Yu J Nat Commun; 2012 Jun; 3():911. PubMed ID: 22713753 [TBL] [Abstract][Full Text] [Related]
37. Structure and lipid-binding properties of the kindlin-3 pleckstrin homology domain. Ni T; Kalli AC; Naughton FB; Yates LA; Naneh O; Kozorog M; Anderluh G; Sansom MS; Gilbert RJ Biochem J; 2017 Feb; 474(4):539-556. PubMed ID: 27974389 [TBL] [Abstract][Full Text] [Related]
38. Mechanism of human PTEN localization revealed by heterologous expression in Dictyostelium. Nguyen HN; Afkari Y; Senoo H; Sesaki H; Devreotes PN; Iijima M Oncogene; 2014 Dec; 33(50):5688-96. PubMed ID: 24292679 [TBL] [Abstract][Full Text] [Related]
39. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN. Downes CP; Bennett D; McConnachie G; Leslie NR; Pass I; MacPhee C; Patel L; Gray A Biochem Soc Trans; 2001 Nov; 29(Pt 6):846-51. PubMed ID: 11709086 [TBL] [Abstract][Full Text] [Related]
40. Catalysis by the tumor-suppressor enzymes PTEN and PTEN-L. Johnston SB; Raines RT PLoS One; 2015; 10(1):e0116898. PubMed ID: 25607987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]